Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Korea Otsuka Pharmaceutical Co.,Ltd. Otsuka Pharmaceutical Co., Ltd. |
---|---|
Information provided by: | Korea Otsuka Pharmaceutical Co.,Ltd. |
ClinicalTrials.gov Identifier: | NCT00549952 |
to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients
Condition | Intervention |
---|---|
Oral Mucositis |
Other: no intervention study |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients |
Ages Eligible for Study: | 19 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Yonghui Jeong | 82-2-3465-3956 | jeongyh@otsuka.co.kr |
Contact: Boyoun Seo | 82-2-3465-5485 | byseo@otsuka.cokr |
Korea, Republic of | |
Seoul National University hospital | Recruiting |
Seoul, Korea, Republic of, 110-744 | |
Principal Investigator: Do-Youn Oh |
Principal Investigator: | Do-Youn Oh, PhD | Seoul National University Hospital |
Study ID Numbers: | 256-KOB-0701 |
Study First Received: | October 25, 2007 |
Last Updated: | October 25, 2007 |
ClinicalTrials.gov Identifier: | NCT00549952 |
Health Authority: | South Korea: Institutional Review Board |
Mouth Diseases Digestive System Diseases Stomatitis Mucositis |
Gastrointestinal Diseases Stomatognathic Diseases Gastroenteritis |